The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder.
Bipolar disorder
CMap
drug discovery
drug repurposing
gene expression signature
Journal
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
ISSN: 1814-1412
Titre abrégé: World J Biol Psychiatry
Pays: England
ID NLM: 101120023
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
pubmed:
30
6
2018
medline:
28
4
2021
entrez:
30
6
2018
Statut:
ppublish
Résumé
To create a gene expression signature (GES) to represent the biological effects of a combination of known drugs for bipolar disorder (BD) on cultured human neuronal cells (NT2-N) and rat brains, which also has evidence of differential expression in individuals with BD. To use the GES to identify new drugs for BD using Connectivity Map (CMap).
Identifiants
pubmed: 29956574
doi: 10.1080/15622975.2018.1492734
doi:
Substances chimiques
Pharmaceutical Preparations
0
Quetiapine Fumarate
2S3PL1B6UJ
Lamotrigine
U3H27498KS
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM